UltraGreen.ai
Singapore’s UltraGreen.ai delivers 24 percent revenue growth in FY2025 to $142.4M
UltraGreen.ai Limited, the Singapore-based fluorescence-guided surgery and digital health solutions provider backed by Temasek entity 65 Equity Partners, has delivered 24 percent revenue growth in the financial year ended December 31, 2025 (FY2025) to $142.4 million.
UltraGreen.ai secures dual regulatory approvals in Philippines and Malaysia
UltraGreen.ai Limited, a Singapore-based fluorescence-guided surgery and digital health solutions firm, has announced the regulatory approvals for both its Verdye (indocyanine green for injection) in the Philippines and its IC-Flow Imaging System V2 in Malaysia.
UltraGreen.ai receives strong demand for $400M SGX IPO
UltraGreen.ai Limited, a Singapore-based fluorescence-guided surgery (FGS) space firm, has received strong investor demand for its $400 million initial public offering (IPO) in the Singapore Stock Exchange.
UltraGreen.ai launches IPO in SGX mainboard to raise over $400M
UltraGreen.ai Limited, a Singapore-based fluorescence-guided surgery (FGS) space firm, has proposed an initial public offering and listing on the main board of the Singapore Stock Exchange, to raise over $400 million.
